The state medical cannabis questions that are being decided by voters Nov. 3 have interesting — and potentially troublesome — qualities, National Organization for the Reform of Marijuana Laws Executive Director Erik Altieri told Benzinga.
South Dakota
The Mount Rushmore State has dual questions concerning the legalization of both medical and adult use markets.
If voters approve both, South Dakota would become the first state to approve both cannabis markets simultaneously.
Altieri credits medical and adult use advocates in the state for their collaborative efforts.
“Instead of trying to compete with each other, they really teamed up,” he said.
As a result, Altieri said prospects appear strong heading into November.
"We fully expect that South Dakota will join the very large list of medical states," he said, citing NORML's expectations. "The polling is looking very favorable."
A recently released poll of South Dakota voters found that 60% of respondents said they plan to vote for legalization.
Mississippi
Mississippi voters will also decide on two cannabis ballot initiatives. The Magnolia State is deciding on two medical cannabis bills.
The ballot questions, Initiative 65 and Initiative 65A, represent rather different options for the medical market.
"The [Initiative 65] that was placed on the ballot by advocates was a very patient-focused and strong ballot initiative," Altieri said.
It includes a broad license system for businesses and ensures reasonable access for patients in every municipality, he said.
State lawmakers had other ideas in mind. Initiative 65A "basically took all the teeth out of the medical bill," which includes a ban on smokeable flower, the NORML executive director said.
Despite the confusion, he expressed confidence in Mississippi voters, who he said "are pretty informed."
A survey conducted by FM3 Research found that likely voters supported Initiative 65 over the competing bill, 52% to 23%.
Nebraska
Nebraskans were set to vote on medical cannabis come Election Day.
Those prospects were dashed on Sept. 10, when the state Supreme Court voted to remove the question from the ballot.
The ruling comes after it was determined the question violated the state's single question rule, making it unconstitutional.
Many advocacy groups panned the decision.
"Even though it's 2020, prohibition is still alive and well,” Altieri said of the development.
"Through some real diligence and legal maneuvering of our opponents, instead of letting the people have their voice heard on medical marijuana in Nebraska, they decided to take the undemocratic route, and force it off the ballot any way they could."
With the vote off, advocates now appear poised to push the measure in 2022.
Altieri said a revised proposal could be made more restrictive to avoid similar issues, though nothing is certain at this time.
Other State Efforts Thwarted in 2020
The upcoming 2020 general election once represented a possible wave of legalization efforts for the cannabis movement.
That did not come to pass, as the COVID-19 pandemic upended much of the momentum.
Social distancing and other safety protocols put an end to most or all of the efforts in states such as Idaho and North Dakota, Altieri said.
The NORML exec said 2021 is likely going to be a legislative year, with some states like Vermont and Illinois attempting to legalize through the legislature, with more voter-led initiatives in 2022 and 2024.
Related Links:
Why Election Night Could Be Historic Yet Quirky Day For Adult-Use Cannabis Legalization
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.